NCT06561035View on ClinicalTrials.gov

ACL-R Opioid Sparing Study

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

June 30, 2026

Conditions
Anterior Cruciate Ligament Injuries
Interventions
DRUG

Opiate Sparing

Subjects will receive medications in the Opiate Sparing arm for pain control.

DRUG

Opiate Based

Subjects will receive medications in the Opiate Based arm for pain control.

Trial Locations (1)

38138

Campbell Clinic, Memphis

All Listed Sponsors
lead

Campbell Clinic

OTHER